THE hallucinogenic drug, lysergic acid diethylamide (LSD-25), produces in minute doses marked aberrations in mental functions. The psychic symptoms of LSD-25 intoxication resemble aspects peculiar ...

One such psychomimetic agent, lysergic acid diethylamide (LSD-25), exerts both peripheral and central actions1. Some of these effects in various animals and humans are nausea, ...

The 25th compound he synthesized, in 1938, was lysergic acid diethylamide (in German, lyserg-saure-diathylamid), or LSD-25.

A sudden surge of admissions to the Bellevue Psychiatric Division after ingestion of d-lysergic acid diethylamide ... A 25-year-old man was taken to Bellevue Hospital by acquaintances who had ...

Lysergic acid diethylamide-25 was synthesized in a Swiss laboratory in 1938. Early researchers called it “psychotomimetic” because it caused psychosis akin to schizophrenia. In the 1950s, the ...

This experiment led him to synthesize, for the very first time, lysergic acid diethylamide, or LSD-25. This new molecule had a similar shape to nikethamide, but with not so similar effects in the lab.

His studies of ergot, a rye fungus, and its various active compounds, led to the creation of several lysergic acid compounds, and his 25th attempt was aptly named LSD-25.

TOPLINE: The use of lysergic acid diethylamide (LSD) tripled among young adults with past-year depression, results from the annual National Survey on Drug Use and Health (NSDUH) show.The increase ...